Summary:
- The U.S. Food and Drug Administration (FDA) is awarding over $500,000 in funding to analyze the composition and quality of hemp-derived products that are increasing in popularity.
- The goal is to better understand the chemical makeup and potential health impacts of these products, which include cannabinoids like CBD, THC, and other compounds found in hemp.
- The research aims to inform future regulatory decisions and ensure the safety of hemp-derived products as the market continues to expand.